David Feinberg
Showing 1–3 of 3 transcripts.
- Milken Institute51 min
Unlocking Health Data | Global Conference 2025
Richard Lui, Ramin Bastani, David Feinberg, Deborah Kilpatrick, Hon Pak
A panel of healthcare leaders from Healthvana, Oracle Health, Sonder Capital, and Samsung discussed the shift from data-rich but information-poor systems to liquid, human-centric models that prioritize patient trust and interoperability. The group highlighted how AI tools are already reducing clinical burnout, improving predictive accuracy for long-term health events, and enabling dynamic consent mechanisms to protect patient ownership. Looking toward a decade-long horizon, the speakers anticipate a paradigm shift where quantum computing and decentralized care empower patients to manage their health through seamless data integration rather than relying solely on traditional specialist visits.
- Milken Institute1h 1m
Prevention and Innovation for a Healthier Tomorrow | Global Conference 2024
Esther Krofah, Robert Bradway, David Feinberg, Karen Knudsen, Meena Seshamani
Representatives from CMS, the American Cancer Society, Oracle Health, and Amgen convened to address the U.S. healthcare system's inefficiencies, noting that while the sector consumes 20% of GDP, chronic disease prevalence and administrative friction continue to drive costs while outcomes remain misaligned. Key strategies outlined include shifting Medicare toward value-based care with a $2,000 prescription cap, leveraging AI tools like the Oracle Digital Clinical Assistant to reduce physician administrative burdens, and advocating for federal reimbursement of multi-cancer early detection to improve survival rates. The panelists reached a consensus that the current fragmented structure is impoding and requires fundamental structural reforms rather than incremental solutions to successfully integrate prevention, innovation, and data interoperability.
- Milken Institute58 min
Patients: The New Economy of Healthcare
Cynthia Grossman, David Feinberg, Jen Horonjeff, Freda Lewis-Hall, Michael Loeb, Jessica Mega, Cindy Grossman
Addressing a healthcare system where 18% of US GDP is spent with inferior life expectancy outcomes, industry leaders from Pfizer, Geisinger, Verily, and Savvy Cooperative advocate a structural shift toward patient-centric B2P models. These initiatives leverage data democratization, anticipatory medicine, and direct pharmacy discounts to decouple revenue from volume while integrating social determinants of health into clinical care. This transformation aims to eliminate systemic friction and replace traditional waiting rooms with home-based, outcome-driven services that prioritize "years lived well" over mere enrollment metrics.